Cytek Biosciences Highlights Aurora Evo, Recurring Revenue Growth and 2026 Outlook at TD Cowen Conference [Yahoo! Finance]
Cytek Biosciences, Inc. (CTKB)
Company Research
Source: Yahoo! Finance
demand and strong adoption from both pharmaceutical and academic customers since its CYTO launch. Recurring revenue rose to 34% of sales (from 29%) as service and reagents grew 20% YoY, with management targeting ~40% over the next couple of years and Cytek Cloud expanding to 24,000 users (50% YoY) and being embedded in pharma workflows. Financially, Cytek reported $201.5M revenue for 2025 (up 1%), $261.5M cash and continued positive cash flow, while guiding for flat-to-modest instrument growth in 2026 with improved academic sentiment and an expanding installed base seen as a long-term revenue flywheel. Interested in Cytek Biosciences, Inc.? Here are five stocks we like better. Cytek Biosciences (NASDAQ:CTKB) outlined its recent product launches, geographic diversification, and expectations for 2026 during a presentation and fireside chat at TD Cowen's 42nd annual healthcare conference. CEO and Chairman Wenbin Jiang and CFO William McCombe discussed the company's installed base
Show less
Read more
Impact Snapshot
Event Time:
CTKB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTKB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTKB alerts
High impacting Cytek Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
CTKB
News
- Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact [Yahoo! Finance]Yahoo! Finance
- Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional ImpactGlobeNewswire
- How The Cytek Biosciences (CTKB) Story Is Shifting With New Targets And 2026 Guidance [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences Inc (CTKB) Q4 2025 Earnings Call Highlights: Record Revenue Amidst Challenges [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
CTKB
Earnings
- 2/26/26 - Miss
CTKB
Sec Filings
- 3/13/26 - Form 4
- 3/12/26 - Form 4
- 3/12/26 - Form 4
- CTKB's page on the SEC website